Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Rituximab and thalidomide combination therapy for Castleman disease.

Ramasamy K, Gandhi S, Tenant-Flowers M, Ceesay M, Corderoy S, Marcus R, Schey S.

Br J Haematol. 2012 Aug;158(3):421-3. doi: 10.1111/j.1365-2141.2012.09157.x. Epub 2012 May 14. No abstract available.

PMID:
22583139
[PubMed - indexed for MEDLINE]
2.

Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.

Stary G, Kohrgruber N, Herneth AM, Gaiger A, Stingl G, Rieger A.

AIDS. 2008 Jun 19;22(10):1232-4. doi: 10.1097/QAD.0b013e3282fa75ce. No abstract available.

PMID:
18525273
[PubMed - indexed for MEDLINE]
3.

Treatment of unicentric Castleman disease with neoadjuvant rituximab.

Bandera B, Ainsworth C, Shikle J, Rupard E, Roach M.

Chest. 2010 Nov;138(5):1239-41. doi: 10.1378/chest.09-2084.

PMID:
21051400
[PubMed - indexed for MEDLINE]
4.

Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.

Zhao X, Shi R, Jin X, Zheng J.

J Am Acad Dermatol. 2011 Aug;65(2):430-2. doi: 10.1016/j.jaad.2010.01.012. No abstract available.

PMID:
21763571
[PubMed - indexed for MEDLINE]
5.

Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease.

Hoffmann C, Schmid H, Müller M, Teutsch C, van Lunzen J, Esser S, Wolf T, Wyen C, Sabranski M, Horst HA, Reuter S, Vogel M, Jäger H, Bogner J, Arasteh K.

Blood. 2011 Sep 29;118(13):3499-503. doi: 10.1182/blood-2011-02-333633. Epub 2011 Jul 21.

PMID:
21778341
[PubMed - indexed for MEDLINE]
Free Article
6.

Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.

Gérard L, Michot JM, Burcheri S, Fieschi C, Longuet P, Delcey V, Meignin V, Agbalika F, Chevret S, Oksenhendler E, Galicier L.

Blood. 2012 Mar 8;119(10):2228-33. doi: 10.1182/blood-2011-08-376012. Epub 2012 Jan 5.

PMID:
22223822
[PubMed - indexed for MEDLINE]
Free Article
7.

[Castleman's disease, HIV and rituximab].

Valencia ME, López V, Corcuera MT, Del Val D.

Rev Clin Esp. 2012 Feb;212(2):118-9. doi: 10.1016/j.rce.2011.06.010. Epub 2011 Sep 15. Spanish. No abstract available.

PMID:
21924712
[PubMed - indexed for MEDLINE]
8.

Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.

Peker D, Martinez AE, Schwartz MA, Cusnir M.

Clin Adv Hematol Oncol. 2012 Mar;10(3):204-6. No abstract available.

PMID:
22402431
[PubMed - indexed for MEDLINE]
9.

What Is the best treatment for HIV-associated multicentric Castleman disease?

Bower M, Dalla Pria A.

Clin Adv Hematol Oncol. 2012 Mar;10(3):207-9. Review. No abstract available.

PMID:
22402432
[PubMed - indexed for MEDLINE]
10.

Clinical dissection of multicentric Castleman disease.

Shin DY, Jeon YK, Hong YS, Kim TM, Lee SH, Kim DW, Kim I, Yoon SS, Heo DS, Park S, Kim BK.

Leuk Lymphoma. 2011 Aug;52(8):1517-22. doi: 10.3109/10428194.2011.574759. Epub 2011 May 17.

PMID:
21585280
[PubMed - indexed for MEDLINE]
11.

Successful treatment of a patient with HIV-associated multicentric Castleman disease (MCD) with thalidomide.

Jung CP, Emmerich B, Goebel FD, Bogner JR.

Am J Hematol. 2004 Mar;75(3):176-7. No abstract available.

PMID:
14978701
[PubMed - indexed for MEDLINE]
12.

Mixed variant multicentric Castleman disease treated with rituximab: case report.

Mian H, Leber B.

J Pediatr Hematol Oncol. 2010 Nov;32(8):622. doi: 10.1097/MPH.0b013e3181f000e2. No abstract available.

PMID:
20921905
[PubMed - indexed for MEDLINE]
13.

Lenalidomide: a new treatment option for Castleman disease.

Szturz P, Adam Z, Chovancová J, Stehlíková O, Klabusay M, Rehák Z, Koukalová R, Krejčí M, Pour L, Zahradová L, Hájek R, Mayer J.

Leuk Lymphoma. 2012 Oct;53(10):2089-91. doi: 10.3109/10428194.2011.621564. Epub 2011 Dec 5. No abstract available.

PMID:
21902577
[PubMed - indexed for MEDLINE]
14.

Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.

Lee JP, Kim DK, Oh DY, Paik JH, Moon KC, Kim S, Kim YS.

Clin Nephrol. 2011 Feb;75(2):165-70.

PMID:
21255547
[PubMed - indexed for MEDLINE]
15.

How I treat HIV-associated multicentric Castleman disease.

Bower M.

Blood. 2010 Nov 25;116(22):4415-21. doi: 10.1182/blood-2010-07-290213. Epub 2010 Aug 5.

PMID:
20688959
[PubMed - indexed for MEDLINE]
Free Article
16.

Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease.

Reid E, Nooka A, Blackmon J, Lechowicz MJ.

Curr Drug Deliv. 2012 Jan;9(1):41-51. Review.

PMID:
22023215
[PubMed - indexed for MEDLINE]
17.

Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.

van Aalderen MC, Brinkman K, van den Berk GE, Terpstra WE.

Neth J Med. 2010 Feb;68(2):87-90.

PMID:
20167961
[PubMed - indexed for MEDLINE]
Free Article
18.

Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.

Powles T, Stebbing J, Montoto S, Nelson M, Gazzard B, Orkin C, Webb A, Bower M.

Blood. 2007 Dec 1;110(12):4132-3. No abstract available.

PMID:
18024800
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.

Bower M, Newsom-Davis T, Naresh K, Merchant S, Lee B, Gazzard B, Stebbing J, Nelson M.

J Clin Oncol. 2011 Jun 20;29(18):2481-6. doi: 10.1200/JCO.2010.34.1909. Epub 2011 May 9.

PMID:
21555697
[PubMed - indexed for MEDLINE]
Free Article
20.

Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide.

Starkey CR, Joste NE, Lee FC.

Am J Hematol. 2006 Apr;81(4):303-4. No abstract available.

PMID:
16550518
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk